Dotbee.ai

Analysis Bruush Oral Care Inc. (BRSH)

6/1/2024

Analysis Bruush Oral Care Inc. (BRSH)

Analysis of Bruush Oral Care Inc. (BRSH)

Bruush Oral Care Inc. is showing some interesting price movements and technical indicators based on the provided data:

1. Price Movement:
- The closing price has been fluctuating between 0.12000 and 0.15800 over the past few days.
- There was a significant drop in price on May 24th, but the price has been relatively stable since then.

2. Relative Strength Index (RSI):
- The RSI values have been consistently above 50, indicating a bullish momentum in the stock.
- The RSI values have been in the range of 54.26896 to 77.12306, showing strong buying interest.

3. Moving Average Convergence Divergence (MACD):
- The MACD indicator has been positive, with the MACD line consistently above the signal line.
- The MACD histogram has been showing an increasing trend, indicating a strengthening bullish momentum.

4. Moving Averages (MA):
- The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been trending upwards.
- The price has been consistently above the moving averages, suggesting a positive trend.

Overall, based on the RSI, MACD, and moving averages, Bruush Oral Care Inc. appears to be in a bullish phase with strong buying interest and positive momentum. However, investors should continue to monitor the price movements and technical indicators for any potential changes in trend.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the transfer agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.

Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%
- Fiscal year ends: September 30, 2023
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%
- Most recent quarter: March 31, 2024
- Return on assets TTM: 22.073999%
- Return on equity TTM: 147.25%

Stock statistics:
- Short ratio: 1.53
- Float shares: 15,308,320,742
- Shares short: 99,287,450
- Avg 10 volume: 46,860,048
- Avg 90 volume: 57,498,254
- Shares outstanding: 15,334,099,968
- Percent held by insiders: 5.22%
- Percent held by institutions: 57.589%
- Short percent of shares outstanding: 0.65%

Valuations metrics:
- PEG ratio: 26.319502
- Forward PE: 26.319502
- Trailing PE: 29.59409
- Enterprise value: $2,950,762,332,160
- Price to book MRQ: 39.3405
- Price to sales TTM: 7.646095
- Enterprise to EBITDA: 22.763
- Enterprise to revenue: 7.732
- Market capitalization: $2,917,925,650,432

Stock price summary:
- Beta: 1.264
- Day 50 MA: $176.2646
- Day 200 MA: $181.0429
- Fifty-two week low: $164.08
- Fifty-two week high: $199.62
- Fifty-two week change: 6.853%

Dividends and splits:
- Payout ratio: 14.93%
- Dividend date: May 16, 2024
- Last split date: August 31, 2020
- Ex-dividend date: May 10, 2024
- Last split factor: 4-for-1 split
- Forward annual dividend rate: $1
- 5-year average dividend yield: 0.73%
- Forward annual dividend yield: 0.5255%
- Trailing annual dividend rate: $0.97
- Trailing annual dividend yield: 0.5097%

Income statement 💸

Here are the revenue figures for the company over the past four fiscal years:

1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000

From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to FY 2023, there was a general upward trend in sales over the previous years.
- The highest sales figure was recorded in FY 2022.

These trends in revenue can provide insights into the company's performance and market conditions over the specified period.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to finance its operations over the years.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on generating positive cash flows from operating activities.

Earnings estimate

Based on the analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.

3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.

4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a further growth trajectory from the EPS of $6.10 in the current year.

Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of improvement and growth in the upcoming quarters and years.

Revenue estimate

The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.

For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, representing a 2% increase from the same quarter last year. The number of analysts providing estimates is 25.

Looking ahead to the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a projected growth rate of 3% compared to the previous year. The number of analysts remains at 25.

For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates has increased to 38.

In the following fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a more significant growth rate of 6% compared to the current fiscal year. The number of analysts remains at 38.

Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly increasing number of analysts providing forecasts.

Growth estimates

Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.

These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It indicates a steady but slightly slower growth trajectory for the company in the near future.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, suggesting that there may be potential for the security to increase in value according to the analysts' predictions.

MACD of BRSH

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link